RMCM
TEVA icon

Reynders McVeigh Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Reynders McVeigh Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-34,803
Closed -$1.16M – 220
2017
Q2 		$1.16M Sell
34,803
-27,531
-44% -$852K 0.15% 88
2017
Q1 		$2M Sell
62,334
-65,118
-51% -$2.22M 0.27% 71
2016
Q4 		$4.62M Sell
127,452
-40,826
-24% -$1.63M 0.66% 41
2016
Q3 		$7.74M Buy
168,278
+2,670
+2% +$139K 1.13% 26
2016
Q2 		$8.32M Buy
165,608
+12,758
+8% +$679K 1.21% 22
2016
Q1 		$8.18M Sell
152,850
-2,705
-2% -$159K 1.21% 22
2015
Q4 		$10.2M Sell
155,555
-1,365
-0.9% -$84.4K 1.67% 19
2015
Q3 		$8.86M Sell
156,920
-3,584
-2% -$232K 1.54% 22
2015
Q2 		$9.49M Sell
160,504
-2,195
-1% -$135K 1.55% 23
2015
Q1 		$10.1M Sell
162,699
-5,171
-3% -$301K 1.74% 21
2014
Q4 		$9.65M Sell
167,870
-646
-0.4% -$36K 1.69% 23
2014
Q3 		$9.06M Sell
168,516
-9,935
-6% -$526K 1.72% 22
2014
Q2 		$9.35M Sell
178,451
-15,160
-8% -$775K 2.13% 14
2014
Q1 		$10.2M Sell
193,611
-18,970
-9% -$877K 2.42% 12
2013
Q4 		$8.52M Sell
212,581
-22,485
-10% -$885K 2.11% 13
2013
Q3 		$8.88M Sell
235,066
-3,285
-1% -$128K 2.46% 10
2013
Q2 		$9.34M Buy
+238,351
New +$9.28M 2.77% 9

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Reynders McVeigh Capital Management's TEVA Position: Q3 2017 in Review

Reynders McVeigh Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 34,803 shares — an estimated $1.16M sold.

Reynders McVeigh Capital Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $10.2M in Q1 2014. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Reynders McVeigh Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 34,803 Teva Pharmaceuticals shares in Q3 2017, an estimated $1.16M.
  • Reynders McVeigh Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Reynders McVeigh Capital Management's Teva Pharmaceuticals position peaked at $10.2M in Q1 2014.
  • 536 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.